Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.24 - Poster Session 1 - Clinical Care

    • Type: Poster Session
    • Track: Supportive Care
    • Presentations: 53
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.24-001 - Validation of a Novel Superior Vena Cava Syndrome Identification, Classification, and Management Algorithm

      09:30 - 09:30  |  Author(s): C.R. Thomas, Jr.

      • Abstract

      Loading...

    • +

      P1.24-002 - Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC)

      09:30 - 09:30  |  Author(s): M. Karthaus

      • Abstract

      Loading...

    • +

      P1.24-003 - A comparison of the Lung Cancer journey - Metropolitan and Non-Metropolitan

      09:30 - 09:30  |  Author(s): B.J. Page

      • Abstract

      Loading...

    • +

      P1.24-004 - Characteristics and Prognostic Analysis of Pulmonary Sarcomatoid Carcinoma

      09:30 - 09:30  |  Author(s): Y. Liang

      • Abstract

      Loading...

    • +

      P1.24-005 - Impressive retinal response to crizotinib in a patient with NSCLC and ALK translocation

      09:30 - 09:30  |  Author(s): A. Bearz

      • Abstract

      Loading...

    • +

      P1.24-006 - Discussion and analysis of lung cancer among young people at our hospital

      09:30 - 09:30  |  Author(s): K. Imasaka

      • Abstract

      Loading...

    • +

      P1.24-007 - Long-term maintenance therapy with bevacizumab for Chinese advanced non-small cell lung cancer: a case report

      09:30 - 09:30  |  Author(s): Z. Liu

      • Abstract

      Loading...

    • +

      P1.24-008 - Are patients' needs being met after-hours? An evaluation of phone calls made after hours for patients with thoracic malignancies.

      09:30 - 09:30  |  Author(s): M.I. Patel

      • Abstract

      Loading...

    • +

      P1.24-009 - Primary Giant and Destructive Hydatide Disease Mimicking Malign Tumor of the Chest Wall: Case Report and Literature Rewieve

      09:30 - 09:30  |  Author(s): A. Erdogan

      • Abstract

      Loading...

    • +

      P1.24-010 - Successful rechalenge of erlotinib in patient with non-small cell lung cancer - regain of tyrosine kinase sensitivity. Case report

      09:30 - 09:30  |  Author(s): E. Chmielowska

      • Abstract

      Loading...

    • +

      P1.24-011 - Exercise as a strategy for rehabilitation / palliation in Advanced Stage Lung Cancer Patients

      09:30 - 09:30  |  Author(s): M. Quist

      • Abstract

      Loading...

    • +

      P1.24-012 - How to Build a Better Lung Cancer Support Group: Best practices from Australia, the United Kingdom and the United States

      09:30 - 09:30  |  Author(s): M. Rigney

      • Abstract

      Loading...

    • +

      P1.24-013 - Prophylaxis against pulmonary thromboembolism with unfractionated heparin for the patients undergoing pulmonary resection for lung cancer

      09:30 - 09:30  |  Author(s): T. Takemoto

      • Abstract

      Loading...

    • +

      P1.24-014 - Metastatic angiosarcoma presenting as haemoptysis and severe pain on the back

      09:30 - 09:30  |  Author(s): M.G. Ortakoylu

      • Abstract

      Loading...

    • +

      P1.24-015 - Chemoradiotherapy-associated myelosuppression: Analysis of risk factors for patients with non-small cell lung cancer

      09:30 - 09:30  |  Author(s): U. Yilmaz

      • Abstract

      Loading...

    • +

      P1.24-016 - Single agent oral etoposide for elderly and infirm advanced non small cell lung cancer : A reasonable therapeutic option

      09:30 - 09:30  |  Author(s): K. Rathnam

      • Abstract

      Loading...

    • +

      P1.24-017 - Monitoring of patients under treatment with single fraction of SBRT in lung lesions.

      09:30 - 09:30  |  Author(s): D. Najjari

      • Abstract

      Loading...

    • +

      P1.24-018 - Characteristics of patients with lung cancer with venous thromboembolism: A post hoc analysis of 676 patients enrolled to the CLOT trial

      09:30 - 09:30  |  Author(s): K. Subramaniam

      • Abstract

      Loading...

    • +

      P1.24-019 - Therapeutic and preventive effects of aprepitant for chemotherapy-induced nausea and vomiting in Japanese patients with thoracic malignancies

      09:30 - 09:30  |  Author(s): S. Ito

      • Abstract

      Loading...

    • +

      P1.24-020 - Efficacy and safety of carboplatin and pemetrexed for the first line treatment of unfit patients to receive cisplatin with nonsquamous non small cell lung cancer

      09:30 - 09:30  |  Author(s): G. Esquerdo

      • Abstract

      Loading...

    • +

      P1.24-021 - Bronchoplasty and bronchoangioplasty for primary non-small cell lung cancer

      09:30 - 09:30  |  Author(s): N. Yamasaki

      • Abstract

      Loading...

    • +

      P1.24-022 - mHealth Tool for Lung Cancer - Development and Demonstration

      09:30 - 09:30  |  Author(s): J.K. Cataldo

      • Abstract

      Loading...

    • +

      P1.24-023 - Envoy Service, a form of dignity therapy, designed to assist communication and palliative care decision for patients with advanced cancer: a preliminary report.

      09:30 - 09:30  |  Author(s): S.W. Shin

      • Abstract

      Loading...

    • +

      P1.24-024 - Acute Exacerbation of Idiopathic Interstitial Pneumonia After Resection of Lung Cancer: Investigation of Pre Operative CT predictor

      09:30 - 09:30  |  Author(s): M.Y. Kim

      • Abstract

      Loading...

    • +

      P1.24-025 - Palliation of Malignant Pleural Effusion by Pleurodesis a comparative study

      09:30 - 09:30  |  Author(s): A.M. Abdelrahman

      • Abstract

      Loading...

    • +

      P1.24-026 - Lung Cancer - You can avoid it, get it, survive it; An evaluation of the Irish Cancer Society's annual lung cancer awareness campaign from 2011 - 2013.

      09:30 - 09:30  |  Author(s): A. Mc Namara

      • Abstract

      Loading...

    • +

      P1.24-027 - Intrapulmonary recurrence after computed tomography-guided percutaneous needle biopsy of stage I lung cancer

      09:30 - 09:30  |  Author(s): Y.K. Kye

      • Abstract

      Loading...

    • +

      P1.24-028 - Chemical pleurodesis using mistletoe extraction (ABNOVAviscumⓇ Injection) for malignant pleural effusion

      09:30 - 09:30  |  Author(s): J.S. Cho

      • Abstract

      Loading...

    • +

      P1.24-029 - Metastatectomy for lung cancer and lung resection for metastases - our experience

      09:30 - 09:30  |  Author(s): S. Krishnamurthy

      • Abstract

      Loading...

    • +

      P1.24-030 - A rare case of synchronous and metachronous lung cancers

      09:30 - 09:30  |  Author(s): P.Q.L. Bui

      • Abstract

      Loading...

    • +

      P1.24-031 - Confirmation of surgical margin of resected pulmonary adenocarcinoma with lepidic growth with thin slice CT of the resected specimen during surgery

      09:30 - 09:30  |  Author(s): Y. Hida

      • Abstract

      Loading...

    • +

      P1.24-032 - Is tuberculosis a challenge for the management of lung cancer?

      09:30 - 09:30  |  Author(s): D. Koksal

      • Abstract

      Loading...

    • +

      P1.24-033 - A rare case: lung cancer and multiple myeloma

      09:30 - 09:30  |  Author(s): A. Bahadir

      • Abstract

      Loading...

    • +

      P1.24-034 - Cystic and cavitary appearance:an usual form of pulmonary metastasis of primer lung adenocarcinoma

      09:30 - 09:30  |  Author(s): A. Bahadir

      • Abstract

      Loading...

    • +

      P1.24-035 - Times to presentation and treatment : A prospective comparision of rural and urban lung cancer patients in North Queensland

      09:30 - 09:30  |  Author(s): A. Joshi

      • Abstract

      Loading...

    • +

      P1.24-036 - Combined Modality Treatment for inoperable Non-Small Cell Lung Cancer - a retrospective study from a New Zealand regional cancer centre.

      09:30 - 09:30  |  Author(s): W. Tsai

      • Abstract

      Loading...

    • +

      P1.24-037 - Addition of bevacizumab to standard palliative chemotherapy in advanced non squamous cell lung carcinoma: Tata Memorial Hospital experience.

      09:30 - 09:30  |  Author(s): A. Joshi

      • Abstract

      Loading...

    • +

      P1.24-038 - Barriers and facilitators to physical activity receiving chemotherapy for lung cancer: an exploratory study

      09:30 - 09:30  |  Author(s): S. Mas

      • Abstract

      Loading...

    • +

      P1.24-039 - Outcome of a series of 25 consecutive patients aged 84 and more with stage IV NSCLC : an invitation to systemic treatment

      09:30 - 09:30  |  Author(s): J. Gantzer

      • Abstract

      Loading...

    • +

      P1.24-040 - Management of solid lung malignancy by CT-guided percutaneous catheter ablation --- Does adjuvant chemotherapy help?

      09:30 - 09:30  |  Author(s): P. Andrew

      • Abstract

      Loading...

    • +

      P1.24-041 - Follow up of patients with lung cancer: the role of primary care

      09:30 - 09:30  |  Author(s): D.P. Weller

      • Abstract

      Loading...

    • +

      P1.24-042 - Video-assisted thoracic surgery lobectomy for patient receiving induction chemoradiotherapy for locally advanced non-small cell lung cancer

      09:30 - 09:30  |  Author(s): T. Miura

      • Abstract

      Loading...

    • +

      P1.24-043 - Results of a Multidisciplinary Team in the Management of Non-Small Cell Lung Cancer in a Developing Country

      09:30 - 09:30  |  Author(s): L. Corrales-Rodriguez

      • Abstract

      Loading...

    • +

      P1.24-044 - Favorable Survival of Women with Non-Small Cell Lung Cancer (NSCLC) after Resection of Brain Metastases (BM) and Whole Brain Radiotherapy (WBRT)

      09:30 - 09:30  |  Author(s): P.M. Putora

      • Abstract

      Loading...

    • +

      P1.24-045 - A case with long term survival following received paclitaxel as fourth line chemotherapy in refractory-relapsed small-cell lung carcinoma. (On behalf of NT-TOG group)

      09:30 - 09:30  |  Author(s): B. Chewaskulyong

      • Abstract

      Loading...

    • +

      P1.24-046 - How are treated French patients with metastatic lung adenocarcinoma with "uncommon" EGFR mutations? How could we do better?

      09:30 - 09:30  |  Author(s): R. Saffroy

      • Abstract

      Loading...

    • +

      P1.24-047 - A pulmonary neurogenic tumor: Primary pulmonary cellular Schwannoma

      09:30 - 09:30  |  Author(s): T. Isitmangil

      • Abstract

      Loading...

    • +

      P1.24-048 - Stage 1 results of a 2-stage phase II trial of single agent amrubicin in patients with previously treated thymic malignancies

      09:30 - 09:30  |  Author(s): H.A. Wakelee

      • Abstract

      Loading...

    • +

      P1.24-049 - Comparison of information provided by the lung cancer pts through the survey with the Physician's evaluation.

      09:30 - 09:30  |  Author(s): N.G. Pilnik

      • Abstract

      Loading...

    • +

      P1.24-050 - Pilot of a weekly dietetic telephone clinic for thoracic oncology outpatients: a UK cancer centre experience.

      09:30 - 09:30  |  Author(s): G. Howell

      • Abstract

      Loading...

    • +

      P1.24-051 - Video-Assisted Thoracoscopic Surgery (VATS) for diagnosis and therapy in primary and secondary pleuro-pulmonary angiosarcoma

      09:30 - 09:30  |  Author(s): J. Bodner

      • Abstract

      Loading...

    • +

      P1.24-052 - Symptoms and early diagnosis of lung cancer.

      09:30 - 09:30  |  Author(s): M.C. Nicolson

      • Abstract

      Loading...

    • +

      P1.24-053 - Repeated Pulmonary Resections at Pulmonary Metastases Surgery

      09:30 - 09:30  |  Author(s): I. Capov

      • Abstract

      Loading...

  • +

    P1.25 - Poster Session 1 - Nurses

    • Type: Poster Session
    • Track: Nurses
    • Presentations: 6
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.25-001 - The National Lung Cancer Forum for Nurses (NLCFN)

      09:30 - 09:30  |  Author(s): D. Borthwick

      • Abstract

      Loading...

    • +

      P1.25-002 - Testing the feasibility of a lung cancer nurse coordination model during early treatment: phase II study (Clinical Trial in Progress)

      09:30 - 09:30  |  Author(s): A. Serena

      • Abstract

      Loading...

    • +

      P1.25-003 - Characteristics and outcome of unplanned admissions in patients with lung cancer: A longitudinal tertiary center study.

      09:30 - 09:30  |  Author(s): C. Oyen

      • Abstract

      Loading...

    • +

      P1.25-004 - Deep venous thrombosis prevention effect of electrical stimulation of acupoint combinations in elderly bedridden patients after major surgery

      09:30 - 09:30  |  Author(s): L. Hou

      • Abstract

      Loading...

    • +

      P1.25-005 - Patient Safety Framework Role of Oncology nurses in the era of oral cancer treatments in patients with NSCLC: Are we ready?

      09:30 - 09:30  |  Author(s): M. Nematollahi

      • Abstract

      Loading...

    • +

      P1.25-006 - Lung Cancer and Comorbidities: A regional population compared with an urban population

      09:30 - 09:30  |  Author(s): R. Grundy

      • Abstract

      Loading...

  • +

    MO01 - Lung Cancer Biology - Techniques and Platforms

    • Type: Mini Oral Abstract Session
    • Track: Biology
    • Presentations: 10
    • Moderators:S. Lu
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside 204 A+B, Level 2
    • +

      MO01.01 - Next generation sequencing of circulating tumour cells captured by antibody-independent enrichment and matched primary tumours/metastases in patients with non-small cell lung cancer

      10:30 - 10:35  |  Author(s): Y. Teng

      • Abstract

      Loading...

    • +

      MO01.03 - Transitioning To Next Gen Testing Of Lung Carcinoma

      10:35 - 10:40  |  Author(s): W.A. Franklin

      • Abstract

      Loading...

    • +

      MO01.04 - Comparison of Microarray and RNA Sequencing Platforms for Profiling MicroRNAs in Formalin-Fixed, Paraffin-Embedded Non-Small Cell Lung Cancer Specimens

      10:40 - 10:45  |  Author(s): D. Buitrago

      • Abstract

      Loading...

    • +

      MO01.05 - DISCUSSANT

      10:45 - 10:55  |  Author(s): S. Fox

      • Abstract

      No abstract available for this presentation

    • +

      MO01.06 - Screening for drugs that overcome Gefitnib resistance in EGFR mutation-positive non-small cell lung cancer cells.

      10:55 - 11:00  |  Author(s): Y. Xue

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO01.07 - Inhibition of the IGF-1R signaling pathway potentiates responses to ALK inhibitors in both ALK TKI naive and ALK TKI resistant lung cancer

      11:00 - 11:05  |  Author(s): C.M. Lovly

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO01.08 - Identifying Strategies For The Treatment Of Acquired EGFR Tyrosine Kinase Inhibitor Resistance

      11:05 - 11:10  |  Author(s): C. Hasovits

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO01.09 - A novel murine xenograft model using samples obtained by EBUS-TBNA

      11:10 - 11:15  |  Author(s): T. Nakajima

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO01.10 - Integrated molecular characterization of Patient-Derived Tumorgrafts as innovative model for clinical management of Non-Small Cell Lung Cancer

      11:15 - 11:20  |  Author(s): F. Tabbo'

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO01.11 - DISCUSSANT

      11:20 - 11:35  |  Author(s): P. Mack

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO02 - General Thoracic and Minimally Invasive Surgery

    • Type: Mini Oral Abstract Session
    • Track: Surgery
    • Presentations: 11
    • Moderators:M. Tajiri
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside 110 A+B, Level 1
    • +

      MO02.01 - Is Lower Zone Lymph Node Dissection always Mandatory in Patients with Lower Lobe Lung Cancer?

      10:30 - 10:35  |  Author(s): H. Ueno

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.02 - Size decrease of ground-glass nodules should not be end of follow-up, but may be optimal timing of curative surgery

      10:35 - 10:40  |  Author(s): H. Kaneda

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.03 - Surgical intervention strategy for postoperative chylothorax after lung resection - clinical analysis of fifty patients who developed postoperative chylothorax

      10:40 - 10:45  |  Author(s): S. Uchida

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.04 - Safety and long term outcome of repeated lung resection for ipsilateral second primary lung cancer

      10:45 - 10:50  |  Author(s): M. Tsuchida

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.05 - DISCUSSANT

      10:50 - 11:00  |  Author(s): G.E. Darling

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.07 - Effect of Obesity on Peri-Operative Outcomes after Robotic-Assisted Pulmonary Lobectomy: Retrospecitve Analysis of 227 Consecutive Patients

      11:00 - 11:05  |  Author(s): M.R. Thau

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.08 - The Feasibility of Single-incision Video-assisted Thoracoscopic Surgery in Major Pulmonary Resection

      11:05 - 11:10  |  Author(s): H.K. Kim

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.09 - Needle scopic surgery for primary lung cancer: Reduced port surgery in thoracic surgery using fine scope and forceps

      11:10 - 11:15  |  Author(s): M. Tajiri

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.10 - Fluoroscopy-assisted thoracoscopic resection of pulmonary nodules after computed tomography-assisted bronchoscopic metallic coil marking

      11:15 - 11:20  |  Author(s): T. Miyoshi

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.11 - Video-Assisted Thoracic Surgery, Hybrid, versus Open Thoracotomy for Stage I Non-Small Cell Lung Cancer - A Propensity Score Analysis Based on a Multi-institutional Registry

      11:20 - 11:25  |  Author(s): J. He

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      MO02.12 - DISCUSSANT

      11:25 - 11:40  |  Author(s): M. Windsor

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO03 - Thymic Malignancies

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 11
    • Moderators:F. Detterbeck
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Gallery B, Level 1
  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.01 - Genetic polymorphisms of inflammatory and DNA repair pathways, radiation-related esophagitis and pneumonitis in definitive chemoradiation treated non-small cell lung cancer patients.

      10:30 - 10:40  |  Author(s): K. Barrett

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.02 - MicroRNA Signature Predicts Survival in Resectable Small-Cell Lung Cancer

      10:40 - 10:50  |  Author(s): N. Bi

      • Abstract

      Loading...

    • +

      O01.03 - BRM Promoter Variants and Survival Outcomes of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Validation Study in the NCIC Clinical Trials Group (NCIC-CTG) BR24 Clinical Trial

      10:50 - 11:00  |  Author(s): S. Cuffe

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.04 - DISCUSSANT

      11:00 - 11:15  |  Author(s): G. Sozzi

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.05 - EGFR wild-type NSCLC patients with high miR-200c expression can benefit from EGFR-TKI

      11:15 - 11:25  |  Author(s): J. Li

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.06 - Dynamic change in plasma EGFR mutation DNA in response to first line therapy for advanced stage non-small cell lung cancer (NSCLC)

      11:25 - 11:35  |  Author(s): T. Mok

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.07 - Randomized Proteomic Stratified Phase III Study of Second Line Erlotinib (E) versus Chemotherapy (CT) in Patients with Inoperable Non-Small Cell Lung Cancer (PROSE): Secondary Endpoint Analysis

      11:35 - 11:45  |  Author(s): V. Gregorc

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O01.08 - DISCUSSANT

      11:45 - 12:00  |  Author(s): D. Gandara

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O02 - NSCLC - Combined Modality Therapy I

    • Type: Oral Abstract Session
    • Track: Combined Modality
    • Presentations: 8
    • Moderators:W.E.E. Eberhardt
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
    • +

      O02.01 - Geographic differences in the combined-modality treatment of stage III unresectable non-small cell lung cancer: Results from a global phase III trial of tecemotide (L-BLP25)

      10:30 - 10:40  |  Author(s): N. Thatcher

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.02 - Tecemotide (L-BLP25) in unresectable stage III non-small cell lung cancer in the phase III START study: Further endpoint and exploratory biomarker results

      10:40 - 10:50  |  Author(s): P.L. Mitchell

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.03 - Value of Adding Erlotinib to Thoracic Radiation Therapy with Chemotherapy for Stage III Non-Small Cell Lung Cancer: A Prospective Phase II Study

      10:50 - 11:00  |  Author(s): R. Komaki

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.04 - DISCUSSANT

      11:00 - 11:15  |  Author(s): E. Vokes

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.05 - Major pathologic response (≤10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas

      11:15 - 11:25  |  Author(s): J.E. Chaft

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.06 - Predictors of trimodality therapy use and overall survival in patients with stage III non-small cell lung cancer (NSCLC) in the National Cancer Database

      11:25 - 11:35  |  Author(s): M.J. Fidler

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.07 - Is there a survival benefit in patients with stage IIIA(N2) non-small cell lung cancer under neoadjuvant chemotherapy and/or radiotherapy followed by surgery administration: a systematic review and meta-analysis

      11:35 - 11:45  |  Author(s): Y. Xu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O02.08 - DISCUSSANT

      11:45 - 12:00  |  Author(s): E. Vallieres

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O03 - NSCLC - Targeted Therapies I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:J. Ross
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium B, Level 1
    • +

      O03.01 - GALAXY-1: Randomized phase II study of docetaxel with or without ganetespib in advanced lung adenocarcinoma: Results in biomarker sub-groups and all adenocarcinoma patients.

      10:30 - 10:40  |  Author(s): S.S. Ramalingam

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.02 - Randomized Phase-3 trial (INSPIRE) of Necitumumab plus Cisplatin-Pemetrexed versus Cisplatin-Pemetrexed Alone as First-Line Therapy in Stage IV Non-Squamous NSCLC

      10:40 - 10:50  |  Author(s): L. Paz-Ares

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.03 - Outcomes of NSCLC patients on Phase I Trials: The Importance of Molecular and Patient Selection

      10:50 - 11:00  |  Author(s): D.S. Tan

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.04 - DISCUSSANT

      11:00 - 11:15  |  Author(s): B. Besse

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.05 - Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations: Findings from three trials of afatinib in EGFR mutation-positive lung cancer

      11:15 - 11:25  |  Author(s): J.C. Yang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.06 - First-In-Human Evaluation of CO-1686, an Irreversible, Highly, Selective Tyrosine Kinase Inhibitor of Mutations of EGFR (Activating and T790M)

      11:25 - 11:35  |  Author(s): J. Soria

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.07 - Investigation of risk factors for developing interstitial lung disease (ILD) and poor prognostic factors for ILD death in Japanese patients with non-small-cell lung cancer (NSCLC): a final analysis of a large-scale erlotinib surveillance study (POLARSTAR)

      11:35 - 11:45  |  Author(s): K. Kuwano

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O03.08 - DISCUSSANT

      11:45 - 12:00  |  Author(s): F. Cappuzzo

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O04 - Molecular Pathology I

    • Type: Oral Abstract Session
    • Track: Pathology
    • Presentations: 8
    • Moderators:I.I. Wistuba
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
    • +

      O04.01 - Identification of CD74-NRG1, a new recurrent fusion gene in invasive mucinous lung adenocarcinomas of never smokers

      10:30 - 10:40  |  Author(s): L. Fernandez-Cuesta

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.02 - Using NGS for Mutational Profiling of NSCLC in the Clinical Setting

      10:40 - 10:50  |  Author(s): S. Roy Chowdhuri

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.03 - Oncogene Mutations and Novel Transcript Fusions in Lung Adenocarcinoma from Never Smokers

      10:50 - 11:00  |  Author(s): J. Jen

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.04 - DISCUSSANT

      11:00 - 11:15  |  Author(s): I.I. Wistuba

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.05 - Epidemiology of PI3K pathway alterations in patients with metastatic non-small cell lung cancer (NSCLC): findings from the international BASALT-1 study

      11:15 - 11:25  |  Author(s): G.K. Dy

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.06 - An international standardization study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators

      11:25 - 11:35  |  Author(s): M.W. Wynes

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.07 - Distinguish synchronous multiple primary lung cancers from intrapulmonary metastasis by genome sequencing

      11:35 - 11:45  |  Author(s): Y. Liu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      O04.08 - DISCUSSANT

      11:45 - 12:00  |  Author(s): S. Dacic

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O05 - Cancer Control

    • Type: Oral Abstract Session
    • Track: Prevention & Epidemiology
    • Presentations: 8
    • Moderators:N. Van Zandwijk
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1